Skip to main content
OpenTrials
Completed

NCT Number: NCT03947801

Dairy Consumption During a High-intensity, High-volume Training Week in Young Athletes

Our proposed study is a 5-d double-blind randomised cross-over trial, seeking to simulate a training identification camp in competitive adolescent soccer players

The purpose of the proposed study is to investigate whether increased protein consumption by Greek yogurt, compared to an isoenergetic carbohydrate (CHO) control supplement, consumed immediately following exercise training, prior to sleep and between breakfast and lunch, for a week during an intense training period (high volume, high intensity) will:

* Attenuate the pro-inflammatory response (cytokines, acute phase proteins) * Reduced the severity of muscle damage and impairment (creatine kinase) * Maintain performance

Secondary outcome measures:

- Increase bone turnover (in favour of formation)

Completed

Looking for future studies?

Notify Me

Key information

Age range

11 year–16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Elite soccer Development

Welland, Ontario, L3C 1M6, Canada

About this study

The proposed study is a randomized, double-blinded, cross-over trial. The protocol will consist of an information session, two identical training camps consisting of 5 consecutive days of intensified soccer training, differing only by nutritional intervention, and identical pre-and post-training session testing. Each testing block will be separated by 28-d to allow for an adequate wash-out and recovery period, during which participants would resume their regular soccer activities

Study Procedures:

All tests and measurements will be performed within eight-weeks. Specifically, participants will attend 1 information session, two identical pre- and post- training/testing sessions and two identical soccer specific training camps.

Information session:

One week prior to the initial soccer specific training camp, participants will be informed of all tests and procedures that will take place and be familiarized with all testing protocols.

Pre- and Post-training testing:

All participants will be tested twice: on the day before (pre) and day following (post) the 5-d soccer specific training camp. Specifically, Participants, will arrive at the University for pre- and post-training testing in the morning at the same time. Body composition measurements will be performed (e.g., standing/seated height, mass, % body fat) followed by fasted venous blood and saliva sampling. A standardized breakfast would then be provided followed by an adequate rest and digest period before performance testing (~1.5h). Performance testing would include a battery of soccer specific tests that cover, power (counter-movement jump, broad jump), speed (10m and 20m sprint), agility (modified 5-0-5) and aerobic capacity (beep-test). During both pre-and-post-testing sessions participants would consume the same standardised breakfast and perform the same tests in the same order for consistency amongst trials which would be repeated between the two testing blocks.

Soccer training:

The simulated 5-d soccer-specific training will be structured to mimic a heavy-volume, high-intensity training camp. Training sessions would occur at the same time each day in the evening for consistency. Drills/exercises will be administered by a certified technical soccer coach and knowledgeable training staff. Each session will began with a 15 min dynamic warm-up followed by 90 min of soccer-specific training, ending with a 15 min cool-down. The 90 min of soccer-specific training will be performed at maximal effort and consist of agility, sprinting and plyometric exercises as well as ball-handling, small-sided games (rondo) and shooting. Following each training session rating of perceived exertion (RPE) will be measured as an indicator of internal load.

Food/Drink supplement consumption:

During the study, three servings of 160 g of 0% plain GY (~115 kcals, 17 g protein, ~11.5 g carbs, 0 fat), or 30 g of isoenergetic CHO (~115 kcal, 0.04 g protein, ~28.6 g carbs, 0 fat) will be provided to participants immediately following the training session, 1 h prior to bedtime, as well as one serving between breakfast and lunch on the subsequent day. The yogurt will be sweetened or flavored with a non-caloric vanilla flavouring to match the taste of the control supplement. The CHO control supplement group will be an isoenergetic dose of a maltodextrin-based semi-solid pudding. This product will be made from non-fat vanilla pudding powder (1 part), maltodextrin (4 parts) and water. This product has been designed to resemble the consistency and texture of Greek yogurt.

Measurements

Questionnaires: Participant Screening and Medical History, Training History, Food frequency Questionnaire (FFQ), sessional RPE.

Anthropometric and body composition measurements: height, seated height, body mass and body fat percentage (%) using bioelectrical impedance analysis (BIA, InBody520; Biospace Co., Ltd., Seoul, S. Korea).

Somatic maturity: maturity offset (years from the age of peak height velocity) will be calculated based on height, seated height and weight measurements.

Exercise performance: will be examined prior to, as well as following each training intervention week. These tests are common in soccer and athletes are familiar with them. To limit confounding exercise influence on both biochemical and performance parameters, participants will be asked to refrain from other activities outside those prescribed to them during the training sessions and 48h prior to the initial pre-assessment visit.

Venous blood and saliva samples: will be collected on 4 separate occasions (24h prior and 24h following the last training session of each training intervention week). To control for circadian rhythm, the exercise session and related blood and saliva samples will be conducted at the same time of day. Saliva samples will be used to examine endocrine response. Venous blood samples will be used to examine inflammatory markers (cytokines - IL-6, IL-10 and TNF-α), c-reactive protein (CRP), IGF-I and indicators of muscle fatigue/damage (CK). Secondary measures may include irisin, oxidative stress (TBARS and ROS) and bone turnover by examining circulating markers of bone formation (PINP, Osteocalcin, BAP, OPG) and of bone resorption (CTX, TRAP, RANKL).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participant are female within the desired age ranges (11-16y)
  • Participants are competitive soccer players
  • Previous participation in high-performance training environment (periodization)

Exclusion criteria

  • Participant is not female or falls outside of the desired age ranges (11-16y)
  • Chronic/frequent use of medications that could affect inflammatory function - NSAIDS or Corticosteroids.
  • Musculoskeletal injury - resulting in the inability to train and/or perform the baseline/post testing.

Treatment and study plan

Greek Yogurt

Other

Female competitive soccer players (11-16y) will consume 0% plain Greek yogurt immediately following the training session, 1 h prior to bedtime, as well as one serving between breakfast and lunch on the subsequent day.

Isoenergetic carbohydrate

Other

Female competitive soccer players (11-16y) will consume an isoenergetic carbohydrate supplement immediately following the training session, 1 h prior to bedtime, as well as one serving between breakfast and lunch on the subsequent day.

Primary outcomes

  1. Body mass (kg)

    Time frame: 8 weeks

    Anthropometric measures

  2. Height (cm)

    Time frame: 8 weeks

    Anthropometric measures

  3. Seated height (cm)

    Time frame: 8 weeks

    Used to calculate maturity offset in years from peak height velocity

  4. Body fat (%)

    Time frame: 8 weeks

    Body composition

  5. Rate of perceived exertion

    Time frame: 8 weeks

    1-10 scale of perceived exertion

  6. Serum concentrations of BAP (ng/ml)

    Time frame: 8 weeks

    Bone formation marker

  7. Serum concentrations of PINP (ng/ml)

    Time frame: 8 weeks

    Bone formation marker

  8. Serum concentrations of OPG (pg/ml)

    Time frame: 8 weeks

    Bone formation marker

  9. Serum concentrations of CTX (ng/ml)

    Time frame: 8 weeks

    Bone resorption marker

  10. Serum concentrations of TRAP (ng/ml)

    Time frame: 8 weeks

    Bone resorption marker

  11. Serum concentrations of RANKL (pg/ml)

    Time frame: 8 weeks

    Bone resorption marker

  12. Plasma concentrations of irisin (ng/ml)

    Time frame: 8 weeks

    Plasma concentrations of pro-and-anti-inflammatory cytokines

  13. Plasma concentrations of IL-6 (pg/ml)

    Time frame: 8 weeks

    Plasma concentrations of pro-and-anti-inflammatory cytokines

  14. Plasma concentrations of IL-10 (pg/ml)

    Time frame: 8 weeks

    Plasma concentrations of pro-and-anti-inflammatory cytokines

  15. Plasma concentrations of TNF-alpha (pg/ml)

    Time frame: 8 weeks

    Plasma concentrations of pro-and-anti-inflammatory cytokines

  16. Plasma concentrations of CRP (pg/ml)

    Time frame: 8 weeks

    Plasma concentrations of pro-and-anti-inflammatory cytokines

  17. Plasma concentration of creatine kinase (U/L)

    Time frame: 8 weeks

    Muscle damage

Secondary outcomes

  1. Serum concentration of IGF-1 (pg/ml)

    Time frame: 8 weeks

    Serum concentration of IGF-1

  2. Plasma concentration of TBARS

    Time frame: 8 weeks

    Oxidative stress

  3. Plasma concentration of ROS

    Time frame: 8 weeks

    Oxidative stress

  4. Saliva concentrations of cortisol (ug/dl)

    Time frame: 8 weeks

    Endocrine response

  5. Saliva concentrations of testosterone (pg/ml)

    Time frame: 8 weeks

    Endocrine response

  6. Oxidative stress

    Time frame: 8 weeks

    Plasma concentrations of markers of oxidative stress

Other outcomes

  1. Aerobic Capacity - Beep Test

    Time frame: 8 weeks

    Aerobic capacity using the - Beep test; units - distance (m)

  2. Maximal sprint ability

    Time frame: 8 weeks

    Maximal sprint ability using a 20 m sprint test; units - time (s)

  3. Explosive leg power - Vertical jump performance

    Time frame: 8 weeks

    Explosive leg power using the counter-movement jump; units - height (cm)

  4. Agility and Quickness

    Time frame: 8 weeks

    Agility using the 5-10-5 pro-agility test; units - time (s)

Sponsors and collaborators

Lead sponsor

Brock University

Other

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
May 13, 2019
Registry last updated
Jun 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.